Photo by joelfilip from unsplash
Introduction: Tissue plasminogen activator (Alteplase; tPA) is the most commonly used thrombolytic medication for treatment of acute ischemic stroke, and recent research suggests that Tenecteplase ... Click to show full abstract
Introduction: Tissue plasminogen activator (Alteplase; tPA) is the most commonly used thrombolytic medication for treatment of acute ischemic stroke, and recent research suggests that Tenecteplase ...
Keywords:
na1 interfere;
tenecteplase;
abstract experimental;
neuroprotective drug;
drug na1;
experimental neuroprotective
Journal Title: Stroke
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Stroke
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!